Bridgeway Capital Management, LLC Surface Oncology, Inc. Transaction History

Bridgeway Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $0.88 $42,749 - $66,000	-75,000 Reduced 36.14%	132,500 $115,000
Q1 2023 May 15, 2023	BUY	$0.61 - $1.03 $30,500 - $51,500	50,000 Added 31.75%	207,500 $145,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $15,500 - $30,250	-25,000 Reduced 13.7%	157,500 $129,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $86,625 - $173,250	82,500 Added 82.5%	182,500 $190,000
Q1 2022 May 16, 2022	BUY	$2.65 - $5.08 $265,000 - $508,000	100,000 New	100,000 $294,000
Q4 2020 Feb 16, 2021	SELL	$6.87 - $10.48 $725,472 - $1.11 Million	-105,600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.06 - $7.23 $285,890 - $408,495	-56,500 Reduced 34.86%	105,600 $729,000
Q2 2020 Aug 14, 2020	BUY	$1.57 - $6.56 $100,480 - $419,840	64,000 Added 65.24%	162,100 $1.06 Million
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $5,616 - $15,405	-3,900 Reduced 3.82%	98,100 $183,000
Q4 2019 Feb 14, 2020	BUY	$1.17 - $2.33 $16,262 - $32,387	13,900 Added 15.78%	102,000 $192,000
Q3 2019 Nov 14, 2019	BUY	$1.4 - $2.84 $123,339 - $250,204	88,100 New	88,100 $125,000
Q2 2019 Aug 14, 2019	SELL	$2.75 - $4.89 $389,950 - $693,402	-141,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.11 - $5.88 $175,086 - $250,488	42,600 Added 42.94%	141,800 $676,000
Q4 2018 Feb 14, 2019	BUY	$3.65 - $10.69 $362,080 - $1.06 Million	99,200 New	99,200 $421,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.